- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作QQ:1843439339 (微信同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
[Cell Designation细胞株名称] H69AR
Product category
Human cells
Organism
Homo sapiens
Cell type
epithelial cell
Morphology
epithelial
Tissue
Lung
Disease
Carcinoma
Applications
3D cell culture
Cancer research
Characteristics
Growth properties
Adherent
Derivation
The multiple drug resistant cell line H69AR was established from NCI-H69 cells (NTCC HTB-119) that were grown in the presence of increasing concentrations of adriamycin (doxorubicin) over a total of 14 months.
Age
55 years
Ethnicity
White
Gender
Male
Tumorigenic
Yes;
Yes, in nude mice
Comments
The H69AR cell line is approximately 50-fold resistant to adriamycin as compared to the parental NCI-H69 cell line.
The monoclonal antibodies QCRL-1 (NTCC HB-11765) and QCRL-3 (NTCC HB-11766) will react with fixed H69AR cells.
The cell line is cross-resistant to anthracycline analogues including daunomycin, epirubicin, menogaril, and mitoxantrone as well as to acivicin, etoposide, gramicidin D, colchicine, and the Vinca alkaloids, vincristine and vinblastine.
The cells display little or no cross-resistance to bleomycin, 5-fluorouracil, and carboplatin. They have a slight collateral sensitivity to 1-dehydrotestosterone and lidocaine.
The antibodies reacts with MRP (multidrug resistance protein), a 190,000 integral membrane phosphoglycoprotein that is overexpressed in some drug-selected resistant cell lines
Handling information
Unpacking and storage instructions
1.Check all containers for leakage or breakage.
2.Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Complete medium
The base medium for this cell line is NTCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
Temperature
37°C
Handling procedure
To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.
1.Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 minutes).
2.Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.
3.It is recommended that the cryoprotective agent be removed immediately. Centrifuge the cell suspension at approximately 125 x g for 5 to 10 minutes. Discard the supernatant and resuspend the cell pellet in an appropriate amount of fresh growth medium.
4.Transfer the vial contents to an appropriate size vessel. It is important to avoid excessive alkalinity of the medium during recovery of the cells. It is suggested that, prior to the addition of the vial contents, the culture vessel containing the growth medium be placed into the incubator for at least 15 minutes to allow the medium to reach its normal pH (7.0 to 7.6).
5.Incubate the culture at 37°C in a suitable incubator. A 5% CO2 in air atmosphere is recommended if using the medium described on this product sheet.
Quality control specifications
Mycoplasma contamination
Not detected
Population doubling time
Approximately 24 hrs
[Comments相关资料] "Group: Haploid karyotype cell line. Knockout cell: Method=CRISPR/Cas9; HGNC; 4408; GNG5. Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line). Derived from sampling site: Bone marrow."
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
网址:www.biovector.net
您正在向 biovector.net 发送关于产品 H69AR cell line细胞株及完全培养基-BioVector NTCC保藏中心 的询问
- 公告/新闻